Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase
US5656655A · kind A · utility
12Cited by
10References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 1995 |
| Grant date | Aug 12, 1997 |
| Priority date | — |
| Expiry date | May 19, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of inhibiting cell proliferation in a patient suffering from such disorder comprising the administration to the patient of a pharmaceutically effective amount of a pharmaceutical composition containing, in admixture with a pharmaceutically acceptable carrier, a compound, or a pharmaceutically acceptable salt thereof, of the formula ##STR1## wherein the radicals are defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.